$KYTH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in KYTHERA BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in KYTHERA BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in KYTHERA BIOPHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 10,000 | 13,500 | 10,000 | 0 to 10 K |
| Jul 15 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 28.90 | 1,365 | 39,454 | 985,068 | 986.4 K to 985.1 K (-0.14 %) |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 27.10 | 8,190 | 221,912 | 986,433 | 994.6 K to 986.4 K (-0.82 %) |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Option Exercise | M | 0.76 | 4,000 | 3,040 | 78,761 | |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Sell | S | 27.06 | 4,000 | 108,250 | 0 | 4 K to 0 (-100.00 %) |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Buy | M | 0.76 | 4,000 | 3,040 | 4,000 | 0 to 4 K |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 27.07 | 3,225 | 87,298 | 539,436 | 542.7 K to 539.4 K (-0.59 %) |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Option Exercise | M | 0.76 | 4,500 | 3,420 | 4,652 | |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Sell | S | 27.00 | 4,500 | 121,500 | 0 | 4.5 K to 0 (-100.00 %) |
| Jul 01 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Buy | M | 0.76 | 4,500 | 3,420 | 4,500 | 0 to 4.5 K |
| Jun 18 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 26.00 | 1,538 | 39,988 | 542,661 | 544.2 K to 542.7 K (-0.28 %) |
| Jun 18 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 6,000 | 8,100 | 69,416 | |
| Jun 18 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 26.00 | 6,000 | 156,000 | 0 | 6 K to 0 (-100.00 %) |
| Jun 18 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 6,000 | 8,100 | 6,000 | 0 to 6 K |
| Jun 18 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 26.05 | 432 | 11,254 | 994,623 | 995.1 K to 994.6 K (-0.04 %) |
| Jun 18 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 25.51 | 900 | 22,959 | 995,055 | 996 K to 995.1 K (-0.09 %) |
| Jun 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Option Exercise | M | 0.76 | 4,000 | 3,040 | 82,761 | |
| Jun 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Sell | S | 25.00 | 4,000 | 100,000 | 0 | 4 K to 0 (-100.00 %) |
| Jun 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Buy | M | 0.76 | 4,000 | 3,040 | 4,000 | 0 to 4 K |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | Kress Francois | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | FENTON DENNIS M | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | TURNER JOSEPH L | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | SCHNELL DAVID | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 06 2013 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | A | 21.65 | 6,618 | 143,280 | 6,618 | |
| Jun 05 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 21.25 | 6,663 | 141,596 | 995,955 | 1 M to 996 K (-0.66 %) |
| Jun 05 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 22.00 | 656 | 14,432 | 544,199 | 544.9 K to 544.2 K (-0.12 %) |
| Jun 05 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 21.23 | 1,969 | 41,792 | 544,855 | 546.8 K to 544.9 K (-0.36 %) |
| May 31 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Option Exercise | M | 0.76 | 4,000 | 3,040 | 86,761 | |
| May 31 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Sell | S | 22.26 | 4,000 | 89,040 | 0 | 4 K to 0 (-100.00 %) |
| May 31 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Buy | M | 0.76 | 4,000 | 3,040 | 4,000 | 0 to 4 K |
| May 28 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Gift | G | 0.00 | 1,513 | 0 | 1,002,618 | 1 M to 1 M (-0.15 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 24.00 | 280 | 6,720 | 995,429 | 995.7 K to 995.4 K (-0.03 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 24.33 | 600 | 14,600 | 995,709 | 996.3 K to 995.7 K (-0.06 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Sell | S | 23.31 | 6,000 | 139,832 | 996,309 | 1 M to 996.3 K (-0.60 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 24.03 | 200 | 4,806 | 546,824 | 547 K to 546.8 K (-0.04 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 23.33 | 2,362 | 55,111 | 547,024 | 549.4 K to 547 K (-0.43 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 4,000 | 5,400 | 75,416 | |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 24.11 | 4,000 | 96,429 | 0 | 4 K to 0 (-100.00 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 4,000 | 5,400 | 4,000 | 0 to 4 K |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Option Exercise | M | 0.76 | 9,000 | 6,840 | 9,152 | |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Sell | S | 23.63 | 9,000 | 212,685 | 0 | 9 K to 0 (-100.00 %) |
| May 03 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Buy | M | 0.76 | 9,000 | 6,840 | 9,000 | 0 to 9 K |
| Apr 29 2013 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Sell | S | 22.48 | 2,500 | 56,197 | 549,386 | 551.9 K to 549.4 K (-0.45 %) |
| Apr 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Beddingfield III Frederick | Chief Medical Offic ... | Option Exercise | A | 22.49 | 50,000 | 1,124,500 | 50,000 | |
| Apr 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Beddingfield III Frederick | Chief Medical Offic ... | Option Exercise | A | 22.49 | 75,000 | 1,686,750 | 75,000 | |
| Apr 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Beddingfield III Frederick | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Option Exercise | A | 27.50 | 33,600 | 924,000 | 33,600 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President & CEO | Option Exercise | A | 27.50 | 50,400 | 1,386,000 | 50,400 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Walker Patricia S | Chief Medical Offic ... | Option Exercise | A | 27.50 | 13,400 | 368,500 | 13,400 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Walker Patricia S | Chief Medical Offic ... | Option Exercise | A | 27.50 | 20,100 | 552,750 | 20,100 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Option Exercise | A | 27.50 | 13,400 | 368,500 | 13,400 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Webster Jeffrey D | Senior VP, Operatio ... | Option Exercise | A | 27.50 | 20,100 | 552,750 | 20,100 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 27.50 | 13,400 | 368,500 | 13,400 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 27.50 | 20,100 | 552,750 | 20,100 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Option Exercise | A | 27.50 | 13,400 | 368,500 | 13,400 | |
| Feb 12 2013 | KYTH | KYTHERA BIOPHARMAC ... | Klein Keith | General Counsel | Option Exercise | A | 27.50 | 20,100 | 552,750 | 20,100 | |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | David Nathaniel E | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 5,672 | |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | FENTON DENNIS M | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 5,672 | |
| Dec 21 2012 | KYTH | KYTHERA BIOPHARMAC ... | Leonard Keith R | President and CEO | Gift | G | 0.00 | 7,563 | 0 | 1,002,309 | 1 M to 1 M (-0.75 %) |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | Kress Francois | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 0 | |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 5,672 | |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | SCHNELL DAVID | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 5,672 | |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 5,672 | |
| Nov 02 2012 | KYTH | KYTHERA BIOPHARMAC ... | TURNER JOSEPH L | Director | Option Exercise | A | 16.00 | 5,672 | 90,752 | 5,672 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 118,013 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 469,926 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,314,831 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,476 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Buy | C | 0.00 | 118,013 | 0 | 1,914,566 | 1.8 M to 1.9 M (+6.57 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Buy | C | 0.00 | 469,926 | 0 | 1,796,553 | 1.3 M to 1.8 M (+35.42 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Buy | C | 0.00 | 1,325,151 | 0 | 1,326,627 | 1.5 K to 1.3 M (+89,779.88 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Prospect Venture Partners III ... | 10% Owner | Buy | C | 0.00 | 1,476 | 0 | 1,476 | 0 to 1.5 K |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | M | 7.55 | 121,883 | 920,217 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | J | 7.55 | 121,883 | 920,217 | 121,883 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | J | 7.61 | 120,934 | 920,308 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | C | 0.00 | 132,649 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | C | 0.00 | 557,639 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | C | 0.00 | 1,327,936 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Option Exercise | C | 0.00 | 1,476 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Payment of Exercise | F | 19.88 | 46,266 | 919,768 | 2,105,740 | 2.2 M to 2.1 M (-2.15 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Buy | M | 7.55 | 121,883 | 920,217 | 2,152,006 | 2 M to 2.2 M (+6.00 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Buy | C | 0.00 | 132,649 | 0 | 2,030,123 | 1.9 M to 2 M (+6.99 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Buy | C | 0.00 | 557,639 | 0 | 1,897,474 | 1.3 M to 1.9 M (+41.62 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Buy | C | 0.00 | 1,338,359 | 0 | 1,339,835 | 1.5 K to 1.3 M (+90,674.73 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | ARCH VENTURE FUND VI LP | 10% Owner | Buy | C | 0.00 | 1,476 | 0 | 1,476 | 0 to 1.5 K |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | M | 7.55 | 121,883 | 920,217 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | J | 7.55 | 121,883 | 920,217 | 121,883 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | J | 7.61 | 120,934 | 920,308 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 132,649 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 557,639 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,327,936 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,476 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Payment of Exercise | F | 19.88 | 46,266 | 919,768 | 2,105,740 | 2.2 M to 2.1 M (-2.15 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Buy | M | 7.55 | 121,883 | 920,217 | 2,152,006 | 2 M to 2.2 M (+6.00 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 132,649 | 0 | 2,030,123 | 1.9 M to 2 M (+6.99 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 557,639 | 0 | 1,897,474 | 1.3 M to 1.9 M (+41.62 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,338,359 | 0 | 1,339,835 | 1.5 K to 1.3 M (+90,674.73 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,476 | 0 | 1,476 | 0 to 1.5 K |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | M | 7.55 | 2,249 | 16,980 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | J | 7.55 | 2,249 | 16,980 | 2,249 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | J | 7.61 | 2,232 | 16,986 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | M | 7.55 | 1,059 | 7,995 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | J | 7.55 | 1,059 | 7,995 | 1,059 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | J | 7.61 | 1,051 | 7,998 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | M | 7.55 | 118,573 | 895,226 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | J | 7.55 | 118,573 | 895,226 | 118,573 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | J | 7.61 | 117,650 | 895,317 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 2,766 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 1,303 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 145,796 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 8,614 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 4,055 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 453,925 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 19,658 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 9,258 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 1,035,917 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 10,996 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 5,179 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Option Exercise | C | 0.00 | 603,612 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Payment of Exercise | F | 19.88 | 854 | 16,978 | 43,583 | 44.4 K to 43.6 K (-1.92 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Payment of Exercise | F | 19.88 | 402 | 7,992 | 21,361 | 21.8 K to 21.4 K (-1.85 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Payment of Exercise | F | 19.88 | 45,010 | 894,799 | 2,414,649 | 2.5 M to 2.4 M (-1.83 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | M | 7.55 | 2,249 | 16,980 | 44,437 | 42.2 K to 44.4 K (+5.33 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | M | 7.55 | 1,059 | 7,995 | 21,763 | 20.7 K to 21.8 K (+5.11 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | M | 7.55 | 118,573 | 895,226 | 2,459,659 | 2.3 M to 2.5 M (+5.06 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 2,766 | 0 | 42,188 | 39.4 K to 42.2 K (+7.02 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 1,303 | 0 | 20,704 | 19.4 K to 20.7 K (+6.72 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 145,796 | 0 | 2,341,086 | 2.2 M to 2.3 M (+6.64 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 8,614 | 0 | 39,422 | 30.8 K to 39.4 K (+27.96 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 4,055 | 0 | 19,401 | 15.3 K to 19.4 K (+26.42 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 453,925 | 0 | 2,195,290 | 1.7 M to 2.2 M (+26.07 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 19,812 | 0 | 30,808 | 11 K to 30.8 K (+180.17 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 9,330 | 0 | 15,346 | 6 K to 15.3 K (+155.09 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 1,044,048 | 0 | 1,741,365 | 697.3 K to 1.7 M (+149.72 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 10,996 | 0 | 10,996 | 0 to 11 K |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 5,179 | 0 | 6,016 | 837 to 6 K (+618.76 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Samuels Camille D | Director | Buy | C | 0.00 | 603,612 | 0 | 697,317 | 93.7 K to 697.3 K (+644.16 %) |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | M | 7.55 | 2,249 | 16,980 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | J | 7.55 | 2,249 | 16,980 | 2,249 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | J | 7.61 | 2,232 | 16,986 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | M | 7.55 | 1,059 | 7,995 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | J | 7.55 | 1,059 | 7,995 | 1,059 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | J | 7.61 | 1,051 | 7,998 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | M | 7.55 | 118,573 | 895,226 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | J | 7.55 | 118,573 | 895,226 | 118,573 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | J | 7.61 | 117,650 | 895,317 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | C | 0.00 | 2,766 | 0 | 0 | |
| Oct 16 2012 | KYTH | KYTHERA BIOPHARMAC ... | Versant Venture Capital II, LP | 10% Owner | Option Exercise | C | 0.00 | 1,303 | 0 | 0 |